
Keywords: AC; adenocarcinoma; ARCON; accelerated radiotherapy with carbogen breathing and nicotinamide; CA IX; carbonic anhydrase; CCRT; concurrent chemoradiotherapy; CR; complete response; Cu-ATSM,; copper-62 labeled diacetyl-bis (N4-methylthiosemicarbazone); DFS;